Is PMCB or QNCX more undervalued in 2026?

CirclFi compares PharmaCyte Biotech, Inc. (PMCB) and Quince Therapeutics, Inc. (QNCX) using 13 institutional-grade valuation models. PMCB has a Quality of Company score of 5.1/10 while QNCX scores 4.3/10.

Which is a better buy — PMCB or QNCX?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do PMCB and QNCX valuations compare?

PMCB at $0.83 and QNCX at $1.15 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

PMCB vs QNCX Valuation Comparison 2026 — Intrinsic Value Analysis

PMCB

Biological Products, (No Diagnostic Substances)

PharmaCyte Biotech, Inc.

Quality

5.1

out of 10

Value Trap

SAFE

Price

$0.83

Last close

Models

3/13

Active

QNCX

Biological Products, (No Diagnostic Substances)

Quince Therapeutics, Inc.

Quality

4.3

out of 10

Value Trap

LOW

Price

$1.15

Last close

Models

8/13

Active

Model-by-Model Comparison

Model	Type	PMCB Fair Value	PMCB Upside	QNCX Fair Value	QNCX Upside
Bayesian DCF	Intrinsic	—	—	$2.38	+106.7%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$2.46	+194.8%	$4.20	+265.0%
PWERM	Option-Based	$2.23	+167.6%	$1.03	-10.1%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for PMCB vs QNCX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

PMCB vs QNCX — Which Stock Is More Undervalued?

PMCB scores higher with a 5.1/10 quality rating vs QNCX's 4.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing PharmaCyte Biotech, Inc. (PMCB) and Quince Therapeutics, Inc. (QNCX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

PMCB currently trades at $0.83 with a QOC of 5.1/10, while QNCX trades at $1.15 with a QOC of 4.3/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).